SOD3 and eNOS genotypes are associated with SOD activity and NOx

Dong,Xiaolong; Li,Dejun; Liu,Hong; Zhao,Yanyan

doi:10.3892/etm.2014.1720

SOD3 and eNOS genotypes are associated with SOD activity and NOx

Authors:
- Xiaolong Dong
- Dejun Li
- Hong Liu
- Yanyan Zhao
View Affiliations

Affiliations: Department of Clinical Genetics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China, Department of Medical Genetics, China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: May 19, 2014 https://doi.org/10.3892/etm.2014.1720
Pages: 328-334

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oxidative stress, characterized by increased reactive oxygen species production and/or decreased antioxidant enzyme activity, plays an important role in the pathogenesis of hypertension. The identification of molecular markers corresponding to the oxidative stress status of hypertension may assist in the antioxidant therapy of hypertension. In the present study, superoxide dismutase (SOD) and endothelial nitric oxide synthase (eNOS) were analyzed as markers of hypertension responding to oxidative stress. The plasma SOD activity and mononitrogen oxides (NOx) concentration were measured, and the SOD3 Ala58Thr and eNOS Glu298Asp polymorphisms were genotyped in hypertensive patients and normotensive controls. Further association experiments were replicated in an extended population, including 343 hypertensive patients and 290 controls. The results demonstrated that no statistically significant differences in the total SOD activity and NOx concentration were identified between the hypertensive patients and controls. However, the plasma SOD activity levels in the SOD3 Ala/Ala homozygote carriers (80.51±27.68 U/ml) were significantly lower compared with the Thr allele carriers (92.18±16.37 U/ml; P=0.031). In addition, the plasma NOx concentration in the eNOS Glu/Glu homozygote carriers (129.66±59.15 µmol/l) was significantly lower compared with the Asp allele carriers (169.84± 55.18 µmol/l; P=0.010). Notably, the altered SOD activity levels and NOx concentration were in concordance in 56.3% of the 80 participants. Therefore, the concordance of decreased SOD activity and NOx concentration, combined with genotypes of SOD3 Ala/Ala and/or eNOS Glu/Glu in hypertensive patients, may be useful in directing the antioxidant therapy of hypertension.

View Figures

View References

1	Panza JA, Quyyumi AA, Brush JE Jr and Epstein SE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 323:22–27. 1990. View Article : Google Scholar : PubMed/NCBI
2	Panza JA, Casino PR, Kilcoyne CM and Quyyumi AA: Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 87:1468–1474. 1993. View Article : Google Scholar : PubMed/NCBI
3	Perticone F, Ceravolo R, Pujia A, et al: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 104:191–196. 2001. View Article : Google Scholar : PubMed/NCBI
4	Le Brocq M, Leslie SJ, Milliken P and Megson IL: Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid Redox Signal. 10:1631–1674. 2008.PubMed/NCBI
5	Strålin P, Karlsson K, Johansson BO and Marklund SL: The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 15:2032–2036. 1995.PubMed/NCBI
6	Kuzkaya N, Weissmann N, Harrison DG and Dikalov S: Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem. 278:22546–22554. 2003. View Article : Google Scholar
7	Laursen JB, Somers M, Kurz S, et al: Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation. 103:1282–1288. 2001. View Article : Google Scholar : PubMed/NCBI
8	Houston MC: The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther Adv Cardiovasc Dis. 4:165–183. 2010. View Article : Google Scholar
9	Sherman DL, Keaney JF Jr, Biegelsen ES, et al: Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension. 35:936–941. 2000. View Article : Google Scholar : PubMed/NCBI
10	Engelhard YN, Gazer B and Paran E: Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J. 151:1002006. View Article : Google Scholar : PubMed/NCBI
11	Block G, Mangels AR, Norkus EP, et al: Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension. 37:261–267. 2001. View Article : Google Scholar : PubMed/NCBI
12	Ward NC, Wu JH, Clarke MW, et al: The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens. 25:227–234. 2007. View Article : Google Scholar : PubMed/NCBI
13	Taniguchi N: Superoxide dismutases: significances in aging, diabetes, ischemia and cancer. Rinsho Byori. 38:876–881. 1990.(In Japanese).
14	Autor AP, Frank L and Roberts RJ: Developmental characteristics of pulmonary superoxide dismutase: relationship to idiopathic respiratory distress syndrome. Pediatr Res. 10:154–158. 1976. View Article : Google Scholar
15	Skrzycki M, Majewska M, Podsiad M and Czeczot H: Expression and activity of superoxide dismutase isoenzymes in colorectal cancer. Acta Biochim Pol. 56:663–670. 2009.PubMed/NCBI
16	Adler S and Huang H: Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am J Physiol Renal Physiol. 287:F907–F913. 2004. View Article : Google Scholar
17	Chu Y, Iida S, Lund DD, et al: Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res. 92:461–468. 2003. View Article : Google Scholar : PubMed/NCBI
18	Zhou L, Xiang W, Potts J, et al: Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension. Free Radic Biol Med. 41:1384–1391. 2006. View Article : Google Scholar : PubMed/NCBI
19	Kumar CA and Das UN: Lipid peroxides, anti-oxidants and nitric oxide in patients with pre-eclampsia and essential hypertension. Med Sci Monit. 6:901–907. 2000.PubMed/NCBI
20	Djordjević VB, Pavlović D, Pejović M, et al: Changes of lipid peroxides and antioxidative factors levels in blood of patients treated with ACE inhibitors. Clin Nephrol. 47:243–247. 1997.PubMed/NCBI
21	Koska J, Syrova D, Blazicek, et al: Malondialdehyde, lipofuscin and activity of antioxidant enzymes during physical exercise in patients with essential hypertension. J Hypertens. 17:529–535. 1999. View Article : Google Scholar : PubMed/NCBI
22	Yamada H, Yamada Y, Adachi T, et al: Polymorphism of extracellular superoxide dismutase (EC-SOD) gene: relation to the mutation responsible for high EC-SOD level in serum. Jpn J Hum Genet. 42:353–356. 1997. View Article : Google Scholar : PubMed/NCBI
23	Campo S, Sardo AM, Campo GM, et al: Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population. Mutat Res. 578:143–148. 2005. View Article : Google Scholar : PubMed/NCBI
24	Sandström J, Nilsson P, Karlsson K and Marklund SL: 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem. 269:19163–19166. 1994.PubMed/NCBI
25	Marklund SL, Nilsson P, Israelsson K, et al: Two variants of extracellular-superoxide dismutase: relationship to cardiovascular risk factors in an unselected middle-aged population. J Intern Med. 242:5–14. 1997. View Article : Google Scholar : PubMed/NCBI
26	Adachi T and Wang XL: Association of extracellular-superoxide dismutase phenotype with the endothelial constitutive nitric oxide synthase polymorphism. FEBS Lett. 433:166–168. 1998. View Article : Google Scholar
27	Yamada H, Yamada Y, Adachi T, et al: Molecular analysis of extracellular-superoxide dismutase gene associated with high level in serum. Jpn J Hum Genet. 40:177–184. 1995. View Article : Google Scholar : PubMed/NCBI
28	Iida R, Tsubota E, Takeshita H and Yasuda T: Multiplex single base extension method for simultaneous genotyping of non-synonymous SNP in the three human SOD genes. Electrophoresis. 29:4788–4794. 2008. View Article : Google Scholar : PubMed/NCBI
29	Ferroni P, Basili S, Paoletti V and Davì G: Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc Dis. 16:222–233. 2006. View Article : Google Scholar : PubMed/NCBI
30	Node K, Kitakaze M, Yoshikawa H, Kosaka H and Hori M: Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension. 30:405–408. 1997. View Article : Google Scholar : PubMed/NCBI
31	Sandrim VC, de Syllos RW, Lisboa HR, Tres GS and Tanus-Santos JE: Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide. 16:348–355. 2007. View Article : Google Scholar : PubMed/NCBI
32	Raman CS, Li H, Martásek P, et al: Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell. 95:939–950. 1998. View Article : Google Scholar
33	Moon J, Yoon S, Kim E, et al: Lack of evidence for contribution of Glu298Asp (G894T) polymorphism of endothelial nitric oxide synthase gene to plasma nitric oxide levels. Thromb Res. 107:129–134. 2002. View Article : Google Scholar : PubMed/NCBI
34	Metzger IF, Souza-Costa DC, Marroni AS, et al: Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics. 15:565–570. 2005. View Article : Google Scholar : PubMed/NCBI
35	Li R, Lyn D, Lapu-Bula R, et al: Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans. Am J Hypertens. 17:560–567. 2004. View Article : Google Scholar : PubMed/NCBI
36	Yoon Y, Song J, Hong SH and Kim JQ: Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem. 46:1626–1630. 2000.PubMed/NCBI
37	Song J, Yoon Y, Park KU, et al: Genotype-specific influence on nitric oxide synthase gene expression, protein concentrations, and enzyme activity in cultured human endothelial cells. Clin Chem. 49:847–852. 2003. View Article : Google Scholar
38	Metzger IF, Sertório JT and Tanus-Santos JE: Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med. 43:987–992. 2007. View Article : Google Scholar : PubMed/NCBI
39	Tamai M, Furuta H, Kawashima H, et al: Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes. Diabetes Res Clin Pract. 71:140–145. 2006. View Article : Google Scholar : PubMed/NCBI
40	Samoila OC, Carter AM, Futers ST, et al: Polymorphic variants of extracellular superoxide dismutase gene in a Romanian population with atheroma. Biochem Genet. 46:634–643. 2008. View Article : Google Scholar : PubMed/NCBI
41	Mansego ML, Solar Gde M, Alonso MP, et al: Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension. J Hypertens. 29:492–500. 2011. View Article : Google Scholar : PubMed/NCBI
42	Naganuma T, Nakayama T, Sato N, et al: A haplotype-based case-control study examining human extracellular superoxide dismutase gene and essential hypertension. Hypertens Res. 31:1533–1540. 2008. View Article : Google Scholar : PubMed/NCBI
43	Miyamoto Y, Saito Y, Kajiyama N, et al: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension. 32:3–8. 1998. View Article : Google Scholar : PubMed/NCBI
44	Lacolley P, Gautier S, Poirier O, et al: Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens. 16:31–35. 1998. View Article : Google Scholar : PubMed/NCBI
45	Kato N, Sugiyama T, Morita H, et al: Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension. 33:933–936. 1999. View Article : Google Scholar : PubMed/NCBI
46	Benjafield AV and Morris BJ: Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hypertens. 13:994–998. 2000. View Article : Google Scholar : PubMed/NCBI
47	Kingah PL, Luu HN, Volcik KA, et al: Association of NOS3 Glu298Asp SNP with hypertension and possible effect modification of dietary fat intake in the ARIC study. Hypertens Res. 33:165–169. 2010. View Article : Google Scholar : PubMed/NCBI
48	Zhao Q, Su SY, Chen SF, Li B and Gu DF: Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese. Chin Med J (Engl). 119:1065–1071. 2006.PubMed/NCBI